NYSE:MCKMcKesson Stock Price, Forecast & News

McKesson's stock was trading at $135.17 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, MCK stock has increased by 12.7% and is now trading at $152.39.
View which stocks have been most impacted by Coronavirus.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 4 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for McKesson.

McKesson is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for McKesson.

McKesson Co. (NYSE:MCK) issued its quarterly earnings data on Monday, August, 3rd. The company reported $2.77 EPS for the quarter, topping the consensus estimate of $2.35 by $0.42. The firm had revenue of $55.68 billion for the quarter, compared to the consensus estimate of $54.16 billion. McKesson had a net margin of 0.40% and a return on equity of 42.33%. McKesson's revenue was down .1% on a year-over-year basis. During the same quarter in the previous year, the company earned $3.31 earnings per share.
View McKesson's earnings history.

McKesson announced a quarterly dividend on Wednesday, July 29th. Shareholders of record on Tuesday, September 1st will be given a dividend of $0.42 per share on Thursday, October 1st. This represents a $1.68 dividend on an annualized basis and a dividend yield of 1.10%. The ex-dividend date is Monday, August 31st. This is an increase from McKesson's previous quarterly dividend of $0.41.
View McKesson's dividend history.

McKesson updated its FY21 earnings guidance on Monday, August, 3rd. The company provided earnings per share (EPS) guidance of $14.70-15.50 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $14.39.

14 brokers have issued 12 month target prices for McKesson's stock. Their forecasts range from $147.00 to $204.00. On average, they anticipate McKesson's stock price to reach $179.08 in the next twelve months. This suggests a possible upside of 17.5% from the stock's current price.
View analysts' price targets for McKesson.

Media coverage about MCK stock has been trending somewhat negative this week, InfoTrie reports. InfoTrie ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. McKesson earned a coverage optimism score of -1.9 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days.
View the latest news about McKesson.

McKesson saw a drop in short interest during the month of July. As of July 31st, there was short interest totaling 2,420,000 shares, a drop of 5.1% from the July 15th total of 2,550,000 shares. Based on an average daily volume of 1,380,000 shares, the short-interest ratio is currently 1.8 days. Approximately 1.5% of the company's stock are sold short.
View McKesson's Short Interest.

Some companies that are related to McKesson include AmerisourceBergen (ABC), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO) and Owens & Minor (OMI).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other McKesson investors own include Walt Disney (DIS), Gilead Sciences (GILD), CVS Health (CVS), AbbVie (ABBV), salesforce.com (CRM), Johnson & Johnson (JNJ), Bank of America (BAC), AT&T (T), UnitedHealth Group (UNH) and Chevron (CVX).

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

McKesson's stock is owned by many different retail and institutional investors. Top institutional investors include Pzena Investment Management LLC (1.85%), LSV Asset Management (1.00%), Scharf Investments LLC (0.55%), Sumitomo Mitsui Trust Holdings Inc. (0.45%), Swiss National Bank (0.39%) and New York State Common Retirement Fund (0.28%). Company insiders that own McKesson stock include Brian S Tyler, Brian Scott Tyler, Britt J Vitalone, Lori A Schechter, M Christine Jacobs, Marie L/Ca Knowles, N Anthony Coles and Sundeep G Reddy.
View institutional ownership trends for McKesson.

MCK stock was sold by a variety of institutional investors in the last quarter, including Prudential PLC, Pzena Investment Management LLC, Morningstar Investment Services LLC, MERIAN GLOBAL INVESTORS UK Ltd, BNP PARIBAS ASSET MANAGEMENT Holding S.A., SG Americas Securities LLC, New York State Common Retirement Fund, and Wedge Capital Management L L P NC. Company insiders that have sold McKesson company stock in the last year include Brian S Tyler, Britt J Vitalone, Lori A Schechter, Marie L/Ca Knowles, and Sundeep G Reddy.
View insider buying and selling activity for McKesson.

MCK stock was acquired by a variety of institutional investors in the last quarter, including UBS Group AG, Mackay Shields LLC, Strs Ohio, Assenagon Asset Management S.A., State of Alaska Department of Revenue, Pendal Group Ltd, Raymond James Financial Services Advisors Inc., and Railway Pension Investments Ltd.
View insider buying and selling activity for McKesson.

Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of MCK stock can currently be purchased for approximately $152.39.

McKesson has a market capitalization of $24.72 billion and generates $231.05 billion in revenue each year. The company earns $900 million in net income (profit) each year or $14.95 on an earnings per share basis. McKesson employs 80,000 workers across the globe.

The official website for McKesson is www.mckesson.com.

McKesson's mailing address is 6555 STATE HWY 161, IRVING TX, 75039. The company can be reached via phone at 972-446-4800 or via email at [email protected]